Second man has gene editing in California as therapy raises no safety flags so far on first one – The Japan Times
The Japan Times |
Second man has gene editing in California as therapy raises no safety flags so far on first one
The Japan Times Madeux also had a severe cough and a partially collapsed lung, but these were deemed unrelated to the gene therapy because he had had similar problems previously. Importantly, there were no signs of harm to his liver. “That’s the big worry” because … |
|
2nd man has gene editing; therapy has no safety flags so far
ABC News A second patient has been treated in a historic gene editing study in California, and no major side effects or safety issues have emerged from the first man’s treatment nearly three months ago, doctors revealed Tuesday. Gene editing is a more precise … |
Gizmodo Australia |
DARPA Exec Warns Biohackers To ‘Think Deeply’ About Injecting Untested Treatments
Gizmodo Australia The therapy had gone through no regulatory approval process and had never before tested in humans. It was not the first time such a bold experiment has taken place in the biohacking community. In October, the company behind the herpes stunt sponsored … |
|
Cancer Stem Cell Therapies Market, 2030
GlobeNewswire (press release) The Cancer Stem Cell Therapies Market, 2017-2030′ report examines the current landscape and the future outlook of the growing pipeline of products targeting CSCs. We identified over 150 molecules that are currently being investigated as therapeutic … |
|
Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
Dove Medical Press Abstract: Genetic variations play an important role in the clinical presentation and progression of Alzheimer’s disease (AD), especially early-onset Alzheimer’s disease. Hundreds of mutations have been reported with the majority resulting from … |